Results 301 to 310 of about 1,457,300 (387)
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
A computer-assisted approach to the analysis of metaphor variation across genres. [PDF]
Hardie, Andrew +3 more
core
The new vision from the National Institute of Allergy and Infectious Diseases (NIAID). [PDF]
Taubenberger JK +2 more
europepmc +1 more source
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette +13 more
wiley +1 more source
Editorial: Unveiling the next generation of cancer immunity & immunotherapy. [PDF]
Sadasivam M, Muniraj N, Thangavel C.
europepmc +1 more source
Objectives Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). The study aimed to externally validate a genetic risk score (GRS) and a combined risk score for predicting the risk of RA‐associated PF in an independent cohort of early‐RA patients. Methods This study utilized an inception cohort of 1118 patients
Mikael Brink +3 more
wiley +1 more source
Antenatal <i>Toxoplasma gondii</i> IgG/IgM seroprevalence at the University Hospital of Cocody. [PDF]
Goran-Kouacou APV +4 more
europepmc +1 more source
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source

